MET and non-small cell lung carcinoma: Further studies have shown that CPNE3 can promote the proliferation, migration and invasion of NSCLC cells mainly through binding of the VWFA domain with the scaffold protein RACK1 and activation of the downstream c‐MET signalling pathway, which can be inhibited by the c‐MET inhibitor JNJ‐38877605.